MedTrace Logo

Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals

NCT07022496 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-06-15

No results posted yet for this study

Summary

Caffeine extracted from green tea to abort acute attack of Migraine

Conditions

  • Migraine
  • Migraine Disease
  • Migraine Headache
  • Migraine Headache, With or Without Aura
  • Migraine, Acute

Interventions

DRUG

Caffeine (200 mg)

caffeine tablets

DRUG

triptans

Sumatriptan

DRUG

NSAID (Nonsteroidal anti-inflammatory drugs)

Aspirin 250 mg, 81 mg, 75 mg

DRUG

Paracetamol (acetaminophen)

Paracetamol 250 mg

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-26
Primary Completion
2025-07-31
Completion
2025-08-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07022496 on ClinicalTrials.gov